£122.35

It has never been this cheap. We have no record of a lower price.

£122 today · cheaper than every other day in the last 3 months

Springer Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 62 days · 62 data points (no recent data)

Historical
Generating forecast…
£122.35 £116.23 £118.68 £121.13 £123.57 £126.02 £128.47 25 July 2026 09 August 2026 24 August 2026 08 September 2026 24 September 2026
View at Amazon ↗

Price data last checked 29 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 62 days • 1 price levels

Days at Price
62 days 0 16 31 47 62 £122 Days at Price

Price Analysis

Most common price: £122 (62 days, 100.0%)

Price range: £122 - £122

Price levels: 1 different prices over 62 days

Description

This book, now in its third edition, examines the current treatment options for first-line, relapsed, and refractory Hodgkin lymphoma and the appropriate management in special clinical circumstances, including in the elderly, pregnant women, and those with nodular lymphocyte-predominant disease (NLPHL). Careful attention is devoted to the emerging individually tailored treatment strategies, including checkpoint inhibition, that are especially appealing given their potential to reduce early and late treatment side effects in this generally young patient population. In addition, clear guidance is provided on the management of Hodgkin survivors. Other topics addressed include epidemiology, pathogenesis, the role of the microenvironment, initial clinical evaluation, imaging diagnosis, use of staging systems, and prognostic factors. The new edition of Hodgkin Lymphoma: A Comprehensive Overview has been revised and updated by key opinion leaders to reflect recent progressin the field. It will be of great value to hematologists, oncologists, and all others with an interest in Hodgkin lymphoma.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
31 March 2020
Listed Since
03 September 2019

Barcode

No barcode data available

Similar Products You Might Like

Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)
99% match

Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)

Springer

£88.34 24 Sep 2026
Non-Hodgkin Lymphoma: Pathology, Imaging, and Current Therapy: 165 (Cancer Treatment and Research, 165)
98% match

Non-Hodgkin Lymphoma: Pathology, Imaging, and Current Therapy: 165 (Cancer Treatment and Research, 165)

Springer

£65.61 22 Sep 2026
Aggressive Lymphomas (Hematologic Malignancies)
98% match

Aggressive Lymphomas (Hematologic Malignancies)

Springer

£89.28 24 Sep 2026
Lymphoma: Diagnosis and Treatment: 43 (Current Clinical Oncology, 43)
97% match

Lymphoma: Diagnosis and Treatment: 43 (Current Clinical Oncology, 43)

Humana

£141.67 18 Sep 2026
Histopathology of Non-Hodgkin’s Lymphomas: (Based on the Updated Kiel Classification)
97% match

Histopathology of Non-Hodgkin’s Lymphomas: (Based on the Updated Kiel Classification)

Springer

£78.11 25 Sep 2026
Blut und Blutkrankheiten: Fünfte Völlig Neu Bearbeitete und Erweiterte Auflage: 2 / 7 (Handbuch der inneren Medizin, 2 / 7)
97% match

Blut und Blutkrankheiten: Fünfte Völlig Neu Bearbeitete und Erweiterte Auflage: 2 / 7 (Handbuch der inneren Medizin, 2 / 7)

Springer

£58.09 03 Oct 2026
Skin Lymphoma: The Illustrated Guide
97% match

Skin Lymphoma: The Illustrated Guide

Wiley

£103.49 21 Aug 2026
Diagnosis and Therapy of Malignant Lymphoma: 46 (Recent Results in Cancer Research, 46)
97% match

Diagnosis and Therapy of Malignant Lymphoma: 46 (Recent Results in Cancer Research, 46)

Springer

£78.01 25 Sep 2026
Lymphoma: Methods and Protocols - Volume 971 Research Guide
97% match

Lymphoma: Methods and Protocols - Volume 971 Research Guide

Humana

£101.40 02 Oct 2026
Lymphoma: Methods and Protocols: 1956 (Methods in Molecular Biology, 1956)
97% match

Lymphoma: Methods and Protocols: 1956 (Methods in Molecular Biology, 1956)

Humana

£122.54 18 Sep 2026
Radiotherapy for Hodgkin Lymphoma
96% match

Radiotherapy for Hodgkin Lymphoma

Springer

£62.16 25 Sep 2026
Lymphoproliferative Diseases of the Skin
96% match

Lymphoproliferative Diseases of the Skin

Springer

£82.92 11 Sep 2026
Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17)
96% match

Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17)

Springer

£60.64 18 Sep 2026
Hematopathology of the Skin: Clinical & Pathological Approach
96% match

Hematopathology of the Skin: Clinical & Pathological Approach

Lippincott Williams & Wilkins

£218.36 25 Aug 2026
Ioachim's Lymph Node Pathology
96% match

Ioachim's Lymph Node Pathology

Lippincott Williams & Wilkins

£201.10 26 Sep 2026
PET/CT in Lymphomas: A Case-Based Atlas
96% match

PET/CT in Lymphomas: A Case-Based Atlas

Springer

£85.16 24 Sep 2026
Tumors of the Lymph Node and Spleen: No. 25 (AFIP Atlas of Tumor Pathology, Series 4,)
96% match

Tumors of the Lymph Node and Spleen: No. 25 (AFIP Atlas of Tumor Pathology, Series 4,)

£132.79 19 Sep 2026
Mantle Cell Lymphoma, An Issue of Hematology/Oncology Clinics of North America: Volume 34-5 (The Clinics: Internal Medicine, Volume 34-5)
96% match

Mantle Cell Lymphoma, An Issue of Hematology/Oncology Clinics of North America: Volume 34-5 (The Clinics: Internal Medicine, Volume 34-5)

Elsevier

£76.79 01 Oct 2026
Resistance to Targeted Therapies in Lymphomas: 21 (Resistance to Targeted Anti-Cancer Therapeutics, 21)
96% match

Resistance to Targeted Therapies in Lymphomas: 21 (Resistance to Targeted Anti-Cancer Therapeutics, 21)

Springer

£71.02 18 Sep 2026